NCT00130234View on ClinicalTrials.gov

Effect of Anti-IgE in Chronic Urticaria

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Urticaria
Interventions
DRUG

Xolair® (Omalizumab)

Trial Locations (1)

21224-6821

Johns Hopkins Asthma and Allergy Center, Baltimore

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Johns Hopkins University

OTHER